Investigation of nanostructured lipid carriers for fast intracellular localization screening using the Echo liquid handler.

Acoustic liquid handling Cellular uptake High-throughput screening Nanomedicine Precision medicine

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
12 Sep 2024
Historique:
received: 14 03 2024
revised: 18 07 2024
accepted: 09 09 2024
medline: 15 9 2024
pubmed: 15 9 2024
entrez: 14 9 2024
Statut: aheadofprint

Résumé

In the field of precision medicine, therapy is optimized individually for each patient, enhancing efficacy while reducing side effects. This involves the identification of promising drug candidates through high-throughput screening on human derived cells in culture. However, screening of drugs which have poor solubility or permeability remains challenging, especially when targeting intracellular components. Therefore, encapsulation of drugs into advanced delivery systems such as nanostructured lipid carries (NLC) becomes necessary. Here we show that the cellular uptake of NLC with different matrix compositions can be assessed in a high-throughput screening system based on acoustic droplet ejection (ADE) technology (Echo liquid handler). Our findings indicate that surface tension and viscosity of the NLC dispersions need to be tailored to enable a reliable ADE transfer. The automated NLC uptake studies indicated that the composition of the matrix, more specifically the amount of oleic acid, significantly influenced cellular uptake. The data obtained were corroborated by imaging based and spectral flow cytometry cellular uptake studies. These findings thus not only provide the basis for a screening tool to rapidly identify the efficacy of NLC uptake but also enable a next step toward precision high-throughput drug screening under consideration of an optimized drug delivery system.

Identifiants

pubmed: 39277150
pii: S0378-5173(24)00932-3
doi: 10.1016/j.ijpharm.2024.124698
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124698

Informations de copyright

Copyright © 2024. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Christina Glader (C)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria; University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, 8010 Graz, Austria. Electronic address: christina.glader@rcpe.at.

Ramona Jeitler (R)

University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, 8010 Graz, Austria. Electronic address: ramona.jeitler@uni-graz.at.

Stefanie Stanzer (S)

CBmed GmbH Stiftingtalstraße 5, 8010 Graz, Stefanie; Medical University of Graz, Division of Oncology, Department of Internal Medicine, Auenbruggerplatz 15, 8036 Graz, Austria. Electronic address: stefanie.stanzer@cbmed.at.

Nora Harbusch (N)

CBmed GmbH Stiftingtalstraße 5, 8010 Graz, Stefanie. Electronic address: nora.harbusch@cbmed.at.

Barbara Prietl (B)

CBmed GmbH Stiftingtalstraße 5, 8010 Graz, Stefanie; Medical University of Graz, Division of Endocrinology and Diabetology, Department of Internal Medicine, Auenbruggerplatz 15, 8036 Graz, Austria. Electronic address: barbara.prietl@cbmed.at.

Amin El-Heliebi (A)

CBmed GmbH Stiftingtalstraße 5, 8010 Graz, Stefanie; Medical University of Graz, Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center, Neue Stiftingtalstraße 6, 8010 Graz, Austria. Electronic address: amin.elheliebi@cbmed.at.

Atida Selmani (A)

University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, 8010 Graz, Austria. Electronic address: atida.selmani@uni-graz.at.

Eleonore Fröhlich (E)

Medical University of Graz, Center for Medical Research, Stiftingtalstraße 24, 8010 Graz, Austria. Electronic address: eleonore.froehlich@medunigraz.at.

Marion Mussbacher (M)

University of Graz, Institute of Pharmaceutical Sciences, Pharmacology & Toxicology, Humboldtstraße 46, 8010 Graz, Austria. Electronic address: marion.mussbacher@uni-graz.at.

Eva Roblegg (E)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria; University of Graz, Institute of Pharmaceutical Sciences, Pharmaceutical Technology & Biopharmacy, Universitätsplatz 1, 8010 Graz, Austria. Electronic address: eva.roblegg@uni-graz.at.

Classifications MeSH